USP17L8
gene geneOn this page
Summary
USP17L8 (ubiquitin specific peptidase 17 like family member 8, HGNC:37181) is a protein-coding gene on chromosome 8p23.1, encoding Inactive ubiquitin carboxyl-terminal hydrolase 17-like protein 8 (P0C7I0).
Predicted to enable cysteine-type deubiquitinase activity. Predicted to be involved in regulation of apoptotic process and regulation of protein stability. Predicted to be located in endoplasmic reticulum. Predicted to be active in cytosol and nucleus.
Source: NCBI Gene 392188 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_001256872
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:37181 |
| Approved symbol | USP17L8 |
| Name | ubiquitin specific peptidase 17 like family member 8 |
| Location | 8p23.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000237038 |
| Ensembl biotype | protein_coding |
| Entrez | 392188 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000527080
RefSeq mRNA: 1 — MANE Select: NM_001256872
NM_001256872
CCDS: CCDS78300
Canonical transcript exons
ENST00000527080 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002198101 | 7971661 | 7973253 |
Expression profiles
Bgee: expression breadth tissue_specific, 1 present calls, max score 41.83.
Top tissues by expression
127 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| colonic epithelium | UBERON:0000397 | 41.83 | gold quality |
| sural nerve | UBERON:0015488 | 40.55 | gold quality |
| stromal cell of endometrium | CL:0002255 | 40.03 | gold quality |
| cortical plate | UBERON:0005343 | 39.84 | gold quality |
| ganglionic eminence | UBERON:0004023 | 39.38 | silver quality |
| bone marrow cell | CL:0002092 | 38.35 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| bone marrow | UBERON:0002371 | 32.86 | gold quality |
| tonsil | UBERON:0002372 | 32.60 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.21 | gold quality |
| liver | UBERON:0002107 | 29.03 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| primary visual cortex | UBERON:0002436 | 27.51 | gold quality |
| placenta | UBERON:0001987 | 27.30 | gold quality |
| leukocyte | CL:0000738 | 27.13 | gold quality |
| monocyte | CL:0000576 | 27.08 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.91 | gold quality |
| urinary bladder | UBERON:0001255 | 26.75 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| blood | UBERON:0000178 | 26.15 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| muscle of leg | UBERON:0001383 | 25.19 | gold quality |
| pancreas | UBERON:0001264 | 24.26 | gold quality |
| frontal cortex | UBERON:0001870 | 24.25 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 24.25 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 24.08 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.20 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Paralogs (71): USP2 (ENSG00000036672), USP28 (ENSG00000048028), USP36 (ENSG00000055483), USP13 (ENSG00000058056), USP33 (ENSG00000077254), USP40 (ENSG00000085982), USP48 (ENSG00000090686), USP14 (ENSG00000101557), USP11 (ENSG00000102226), USP10 (ENSG00000103194), USP31 (ENSG00000103404), USP42 (ENSG00000106346), USP5 (ENSG00000111667), USP4 (ENSG00000114316), USP9Y (ENSG00000114374), USP34 (ENSG00000115464), USP35 (ENSG00000118369), USP45 (ENSG00000123552), USP22 (ENSG00000124422), USP9X (ENSG00000124486), USP6 (ENSG00000129204), USP29 (ENSG00000131864), USP26 (ENSG00000134588), USP30 (ENSG00000135093), USP15 (ENSG00000135655), USP37 (ENSG00000135913), USP44 (ENSG00000136014), USP20 (ENSG00000136878), USP8 (ENSG00000138592), USP3 (ENSG00000140455), USP21 (ENSG00000143258), USP43 (ENSG00000154914), USP25 (ENSG00000155313), USP16 (ENSG00000156256), USP24 (ENSG00000162402), USP1 (ENSG00000162607), USP49 (ENSG00000164663), USP38 (ENSG00000170185), USP50 (ENSG00000170236), USP47 (ENSG00000170242)
Protein
Protein identifiers
Inactive ubiquitin carboxyl-terminal hydrolase 17-like protein 8 — P0C7I0 (reviewed: P0C7I0)
All UniProt accessions (1): P0C7I0
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Nucleus. Endoplasmic reticulum.
Similarity. Belongs to the peptidase C19 family. USP17 subfamily.
RefSeq proteins (1): NP_001243801* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001394 | Peptidase_C19_UCH | Domain |
| IPR018200 | USP_CS | Conserved_site |
| IPR028889 | USP | Domain |
| IPR038765 | Papain-like_cys_pep_sf | Homologous_superfamily |
| IPR050164 | Peptidase_C19 | Family |
Pfam: PF00443
UniProt features (7 total): compositionally biased region 3, region of interest 2, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0C7I0-F1 | 67.51 | 0.46 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-5689880 | Ub-specific processing proteases |
MSigDB gene sets: 14 (showing top):
GOBP_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_REMOVAL, GOMF_CYSTEINE_TYPE_PEPTIDASE_ACTIVITY, GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, GOBP_REGULATION_OF_PROTEIN_STABILITY, GOBP_PROTEOLYSIS, GOMF_PEPTIDASE_ACTIVITY, GOMF_UBIQUITIN_LIKE_PROTEIN_PEPTIDASE_ACTIVITY, REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, REACTOME_DEUBIQUITINATION, REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES, GOBP_REGULATION_OF_PROGRAMMED_CELL_DEATH, GOBP_PROTEIN_MODIFICATION_PROCESS, GOMF_DEUBIQUITINASE_ACTIVITY, chr8p23
GO Biological Process (4): proteolysis (GO:0006508), protein deubiquitination (GO:0016579), regulation of protein stability (GO:0031647), regulation of apoptotic process (GO:0042981)
GO Molecular Function (1): cysteine-type deubiquitinase activity (GO:0004843)
GO Cellular Component (3): nucleus (GO:0005634), endoplasmic reticulum (GO:0005783), cytosol (GO:0005829)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Deubiquitination | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular membrane-bounded organelle | 2 |
| cytoplasm | 2 |
| protein metabolic process | 1 |
| cysteine-type deubiquitinase activity | 1 |
| protein modification by small protein removal | 1 |
| regulation of biological quality | 1 |
| apoptotic process | 1 |
| regulation of programmed cell death | 1 |
| cysteine-type peptidase activity | 1 |
| deubiquitinase activity | 1 |
| endomembrane system | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
74 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| USP17L8 | DEFB108B | Q8NET1 | 448 |
| USP17L8 | DEFB107A | Q8IZN7 | 447 |
| USP17L8 | A0A0G2JN59 | A0A0G2JN59 | 397 |
| USP17L8 | DEFB106A | Q8N104 | 392 |
| USP17L8 | DEFB105A | Q8NG35 | 389 |
| USP17L8 | NUP37 | Q8NFH4 | 349 |
| USP17L8 | DEFB104A | Q8WTQ1 | 311 |
| USP17L8 | LAMTOR1 | Q6IAA8 | 275 |
| USP17L8 | MACROH2A1 | O75367 | 254 |
| USP17L8 | RCE1 | Q9Y256 | 209 |
| USP17L8 | SEPTIN9 | Q9UHD8 | 208 |
| USP17L8 | ZUP1 | Q96AP4 | 204 |
| USP17L8 | DEFB103A | P81534 | 199 |
| USP17L8 | RPRD1B | Q9NQG5 | 186 |
| USP17L8 | UQCRB | P14927 | 137 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A2A5N8, A6NCW0, A6NCW7, A8MUK1, B1AQJ2, B2RQC2, C9J2P7, C9JJH3, C9JLJ4, C9JPN9, C9JVI0, D3ZWK4, D6R901, D6R9N7, D6RA61, D6RBM5, D6RBQ6, D6RCP7, D6RJB6, E9Q9U0, G5E8G2, G5E8I7, O94966, P0C7H9, P0C7I0, P35125, P51784, Q0E2F9, Q0WX57, Q2TAC6, Q3UJD6, Q4KLL9, Q5R7G8, Q5TKR9, Q61068, Q66HE5, Q6J1Y9, Q6PFD6, Q6QN14, Q6R6M4
Diamond homologs: A0A0R4IB93, A0JM59, A5PMR2, A5PN09, A6NNY8, A6QNM7, A7Z056, B1AY13, B1WBD7, D2HBJ8, D6RBM5, E1C213, E7F6T8, E9Q9U0, F6Z5C0, F8VPU6, F8VPZ3, M9PD06, O00507, O22207, O60079, O74442, O94269, O94966, O96612, P0C7I0, P0C8Z3, P0CAQ1, P35125, P39538, P40453, P51784, P53874, P55824, P70398, Q01988, Q09738, Q0V9G5, Q28CN3, Q2HJE4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
104 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 8:7972152:AGG:A | donor_gain | 0.4700 |
| 8:7971962:T:A | donor_gain | 0.4400 |
| 8:7973138:T:TG | acceptor_gain | 0.4400 |
| 8:7972269:TC:T | donor_gain | 0.4300 |
| 8:7972270:CC:C | donor_gain | 0.4300 |
| 8:7972127:CTCTT:C | acceptor_gain | 0.4100 |
| 8:7972216:C:CT | donor_gain | 0.4000 |
| 8:7973046:G:C | donor_gain | 0.4000 |
| 8:7972136:A:C | acceptor_gain | 0.3900 |
| 8:7972036:T:A | donor_gain | 0.3700 |
| 8:7973045:A:AC | donor_gain | 0.3700 |
| 8:7972104:T:TA | donor_gain | 0.3600 |
| 8:7972132:C:CC | acceptor_gain | 0.3600 |
| 8:7972136:A:AC | acceptor_gain | 0.3600 |
| 8:7973058:C:CA | donor_gain | 0.3500 |
| 8:7972108:A:AC | donor_gain | 0.3400 |
| 8:7972109:C:CC | donor_gain | 0.3400 |
| 8:7971976:TTCC:T | donor_gain | 0.3300 |
| 8:7971879:GGGTA:G | donor_loss | 0.3200 |
| 8:7971880:GGTA:G | donor_loss | 0.3200 |
| 8:7971881:GTA:G | donor_loss | 0.3200 |
| 8:7971882:TA:T | donor_loss | 0.3200 |
| 8:7971883:ACCTT:A | donor_loss | 0.3200 |
| 8:7971884:C:CT | donor_loss | 0.3200 |
| 8:7972222:G:A | donor_gain | 0.3200 |
| 8:7972510:T:A | donor_gain | 0.3200 |
| 8:7973139:C:A | acceptor_gain | 0.3200 |
| 8:7971885:CTTC:C | donor_loss | 0.3100 |
| 8:7971774:AGTTC:A | acceptor_gain | 0.3000 |
| 8:7971886:TTCA:T | donor_loss | 0.3000 |
AlphaMissense
3505 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 8:7972663:A:C | F197L | 0.959 |
| 8:7972663:A:T | F197L | 0.959 |
| 8:7972665:A:G | F197L | 0.959 |
| 8:7972762:A:C | F164L | 0.927 |
| 8:7972762:A:T | F164L | 0.927 |
| 8:7972764:A:G | F164L | 0.927 |
| 8:7972795:G:C | F153L | 0.922 |
| 8:7972795:G:T | F153L | 0.922 |
| 8:7972797:A:G | F153L | 0.922 |
| 8:7972141:A:C | F371L | 0.904 |
| 8:7972141:A:T | F371L | 0.904 |
| 8:7972143:A:G | F371L | 0.904 |
| 8:7972405:G:C | F283L | 0.896 |
| 8:7972405:G:T | F283L | 0.896 |
| 8:7972407:A:G | F283L | 0.896 |
| 8:7972667:A:T | I196K | 0.892 |
| 8:7972218:A:G | W346R | 0.878 |
| 8:7972218:A:T | W346R | 0.878 |
| 8:7972753:G:C | F167L | 0.873 |
| 8:7972753:G:T | F167L | 0.873 |
| 8:7972755:A:G | F167L | 0.873 |
| 8:7972664:A:C | F197C | 0.868 |
| 8:7972667:A:C | I196R | 0.830 |
| 8:7972664:A:G | F197S | 0.828 |
| 8:7972665:A:T | F197I | 0.796 |
| 8:7972558:A:C | S232R | 0.792 |
| 8:7972558:A:T | S232R | 0.792 |
| 8:7972560:T:G | S232R | 0.792 |
| 8:7972216:C:A | W346C | 0.783 |
| 8:7972216:C:G | W346C | 0.783 |
dbSNP variants (sampled 300 via entrez): RS1005031588 (8:7972799 C>T), RS1015450215 (8:7972939 G>C), RS1051025708 (8:7973669 G>C), RS1053870155 (8:7975176 T>A), RS112464135 (8:7971306 G>A,C), RS112796125 (8:7973628 T>A), RS113338263 (8:7973667 C>G), RS1157028016 (8:7973912 A>G), RS1158472367 (8:7973062 G>A,C), RS1158959638 (8:7973644 T>C), RS1159446300 (8:7971769 T>G), RS1160589479 (8:7973048 G>A,C,T), RS1160795403 (8:7971936 G>A), RS1161975883 (8:7972074 G>C), RS1162011057 (8:7974225 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.